Get started
Author

Aakriti Adhikari

ORCID: 0000-0003-0799-0468
Observed ORCID: 0000-0003-0799-0468
OpenAlex ID: A5065217776
Applications of Microwaves in Medicine Leveraging Artificial Intelligence: Future Perspectives
2023 · Keerthy Gopalakrishnan, Aakriti Adhikari, et al. · Electronics · 38
PDF
Spontaneous sublingual hematoma secondary to warfarin therapy—A rare complication
2022 · Aakriti Adhikari, Shriya Sharma, et al. · Clinical Case Reports · 8
Digital Pulmonology Practice with Phonopulmography Leveraging Artificial Intelligence: Future Perspectives Using Dual Microwave Acoustic Sensing and Imaging
2023 · Arshia K. Sethi, Pratyusha Muddaloor, et al. · Sensors · 7
PDF
Minimal Change Disease in an Adult: A Case Report
2022 · Shashank Neupane, Prasamsa Pudasaini, et al. · Journal of Nepal Medical Association · 5
PDF
Oxygen Requirement and Associated Risk Factors in Post‐COVID‐19 Patients Admitted to a Tertiary Care Center: A Cross‐Sectional Study
2023 · Bishnu Deep Pathak, Binit Upadhaya Regmi, et al. · Canadian Journal of Infectious Diseases and Medical Microbiology · 4
PDF
Hemophagocytic Lymphohistiocytosis secondary to Rickettsial infection: A case report
2022 · Shriya Sharma, Aakriti Adhikari, et al. · Clinical Case Reports · 4
PDF
Darier Roussy Subcutaneous Sarcoidosis from Nepal: A case report
2022 · Shriya Sharma, Aakriti Adhikari, et al. · Annals of Medicine and Surgery · 4
PDF
Successful medical management of diabetic ketoacidosis at first presentation in a child with type 1 diabetes: A case report
2022 · Shriya Sharma, Aakriti Adhikari, et al. · Annals of Medicine and Surgery · 4
PDF
Sturge–Weber Syndrome with Bilateral Port-Wine Stain
2022 · Bishnu Deep Pathak, Shriya Sharma, et al. · Case Reports in Pediatrics · 4
PDF
Guillain-Barré Syndrome associated with SARS-CoV-2 infection in Nepal: A case report
2022 · Shriya Sharma, Aakriti Adhikari, et al. · Annals of Medicine and Surgery · 2
PDF
Antibiotics Use among Patients with Acute Exacerbation of Chronic Obstructive Pulmonary Disease in the Department of Internal Medicine of a Tertiary Care Centre: A Descriptive Cross-sectional Study
2022 · Ushab Rana Mohsin, Nabin Simkhada, et al. · Journal of Nepal Medical Association · 2
Successful rechallenge of BRAF/MEK inhibitor with ruxolitinib in BRAF/MEK inhibitor-induced hemophagocytic lymphohistiocytosis like hyperinflammatory syndrome in BRAF V600E-mutated lung adenocarcinoma: a case report
2026 · Simran Chandra, Sagar Hansraj, et al. · Frontiers in Oncology · 1
PDF
Influence of HIV status, age and ethnicity on survival in patients with burkitt lymphoma (BL) and diffuse large B cell lymphoma (DLBCL): A real-world nationwide database study
2025 · Himil Mahadevia, Tarunjot Sethi, et al. · Blood · 1
PDF
Impact of adenovirus infection on the long-term cardiovascular and other outcomes following CAR T-cell therapy: A propensity-matched cohort study
2025 · Aakriti Adhikari, Abat Khan, et al. · Blood · 1
AML-1080: Fludarabine/Melphalan vs Fludarabine/Busulfan Conditioning in AML Undergoing Allogeneic HCT
2026 · Aakriti Adhikari, Vasu Bansal, et al. · Clinical Lymphoma Myeloma & Leukemia
POSTER: MM-1086: GLP-1 Receptor Agonists and Venous Thromboembolism Risk in Multiple Myeloma
2026 · Priyanshi Maurya, Ujjwal Soni, et al. · Clinical Lymphoma Myeloma & Leukemia
MM-1086: GLP-1 Receptor Agonists and Venous Thromboembolism Risk in Multiple Myeloma
2026 · Priyanshi Maurya, Ujjwal Soni, et al. · Clinical Lymphoma Myeloma & Leukemia
POSTER: AML-1079: Pretransplant Measurable Residual Disease and Survival After Allogeneic Hematopoietic Cell Transplantation in Acute Myeloid Leukemia: Does Donor Type Change the Risk?
2026 · Aakriti Adhikari, Vasu Bansal, et al. · Clinical Lymphoma Myeloma & Leukemia
POSTER: AML-1080: Fludarabine/Melphalan vs Fludarabine/Busulfan Conditioning in AML Undergoing Allogeneic HCT
2026 · Aakriti Adhikari, Vasu Bansal, et al. · Clinical Lymphoma Myeloma & Leukemia
AML-1079: Pretransplant Measurable Residual Disease and Survival After Allogeneic Hematopoietic Cell Transplantation in Acute Myeloid Leukemia: Does Donor Type Change the Risk?
2026 · Aakriti Adhikari, Vasu Bansal, et al. · Clinical Lymphoma Myeloma & Leukemia
Competing risks of relapse and major organ failure after allogeneic hematopoietic cell transplantation.
2026 · Aakriti Adhikari, Himil Mahadevia, et al. · Journal of Clinical Oncology
Differential clinical and economic signatures of CAR T-cell therapy in multiple myeloma across demographic and payer strata: A national analysis.
2026 · Karnav Modi, Himil Mahadevia, et al. · Journal of Clinical Oncology
Real-world use of fruquintinib in refractory metastatic colorectal cancer in the United States.
2026 · Vasu Bansal, Aakriti Adhikari, et al. · Journal of Clinical Oncology
Impact of geographic distance from transplant center on the risk of severe graft-versus-host disease after allogeneic hematopoietic cell transplantation.
2026 · Aakriti Adhikari, Vasu Bansal, et al. · Journal of Clinical Oncology
Differential clinical and economic signatures of CAR T-cell therapy in DLBCL across demographic and payer strata: A national analysis.
2026 · Karnav Modi, Himil Mahadevia, et al. · Journal of Clinical Oncology
Works count: 30
Citation count: 85
H-index: 4
I10-index: 1
Year
Topic
Type